• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM A. COOK AUSTRALIA, PTY LTD ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number G32542
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code Obstruction/Occlusion (2422)
Date of Event 12/06/2021
Type of Reportable Event Serious Injury
Event or Problem Description
Originally stent was implanted on (b)(6) 2021.2 icast stents were also implanted both of 6x22, placed one on each side of renals respectively (left and right).Notice narrowing on (b)(6) 2021 of the superior mesenteric artery (sma) and the celiac artery with decreased flow.This required stenting of both arteries but information of stents used is unknown.Twisting may have contributed to the occurred event, but this cannot be determined.No twisting occurred during the original procedure.
 
Event or Problem Description
Originally stent was implanted on (b)(6) 2021.2 icast stents were also implanted both of 6x22, placed one on each side of renals respectively (left and right).Notice narrowing on (b)(6) 2021 of the superior mesenteric artery (sma) and the celiac artery with decreased flow.This required stenting of both arteries but information of stents used is unknown.Twisting may have contributed to the occurred event, but this cannot be determined.No twisting occurred during the original procedure.
 
Event or Problem Description
Originally stent was implanted on (b)(6) 2021.2 icast stents were also implanted both of 6x22, placed one on each side of renals respectively (left and right).Notice narrowing on (b)(6) 2021 of the superior mesenteric artery (sma) and the celiac artery with decreased flow.This required stenting of both arteries but information of stents used is unknown.Twisting may have contributed to the occurred event, but this cannot be determined.No twisting occurred during the original procedure.
 
Additional Manufacturer Narrative
No part of the device was returned for investigation.No images were supplied.The relevant manufacturing records were reviewed and appeared complete and correct.A review of specifications found that there are a number of processes and checks in place which would likely identify a device deficiency prior to shipment.The instructions for use (ifu) supplied with the device states: "inaccurate placement and/or incomplete sealing of the zenith fenestrated aaa endovascular graft within the vessel may result in increased risk of endoleak, migration or inadvertent occlusion of the renal or internal iliac arteries.It is recommended that all vessels accommodated by a small fenestration be stented in order to secure positive alignment of the graft fenestration with the vessel origin." and lists organ impairment/loss due to side-branch vessel occlusion (in particular, renal and/or gastrointestinal impairment/loss) as potential adverse events.Based on the information received a definitive root cause could not be determined.It is possible that one or more of the following factors contributed to the event: -kinking/ collapse/excessive prolapse of implant/folding of implant material between stents -patient related factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH FENESTRATED AAA ENDOVASCULAR GRAFT PROXIMAL BODY
Common Device Name
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane QLD 4 113
AS  QLD 4113
Manufacturer (Section G)
WILLIAM A. COOK AUSTRALIA, PTY LTD
95 brandl street
eight mile plains
brisbane QLD 4 113
AS   QLD 4113
Manufacturer Contact
meena harish
95 brandl street
eight mile plains
brisbane QLD 4-113
AS   QLD 4113
MDR Report Key13064725
Report Number9680654-2021-00022
Device Sequence Number12169816
Product Code MIH
UDI-Device Identifier10827002325422
UDI-Public(01)10827002325422(17)231116(10)AC1069091
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P020018
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/16/2023
Device Model NumberG32542
Device Catalogue NumberZFEN-P-2-28-124-R
Device Lot NumberAC1069091
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 12/07/2021
Supplement Date Received by Manufacturer12/07/2021
Initial Report FDA Received Date12/22/2021
Supplement Report FDA Received Date02/17/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/16/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age62 YR
Patient SexFemale
-
-